Hypercalcemia due to CYP24A1 mutations: a systematic descriptive review.
Daniele CappellaniAlessandro BrancatellaRiccardo MorgantiSimona BorsariFulvia BaldinottiMaria Adelaide CaligoMartin KaufmannGlenville JonesClaudio MarcocciFilomena CetaniPublished in: European journal of endocrinology (2021)
CYP24A1 loss-of-function results in an age-dependent phenotype, which can be exacerbated by triggering factors, such as pregnancy. Although biallelic carriers present more significant clinical and biochemical features, monoallelic carriers have an increased risk of calcium-related conditions. The highly variable tested therapeutic approaches did not allow to draw conclusions on preferable therapeutic regime.